Original Research

The Activity and Safety of Anlotinib for Patients with Extremity Desmoid Fibromatosis: A Retrospective Study in a Single Institution

Zheng C, Zhou Y, Wang Y, Luo Y, Tu C, Min L

Drug Design, Development and Therapy 2020, 14:3941-3950

Published Date: 25 September 2020